435 forecasters

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

0.3%chance

0.3%chance

ResolvedNo

ResolvedNo

The community gave this a 0% chance, and it resolved No.

Forecast Timeline

Authors:

Opened:

Jan 1, 2024

Closes:

Dec 31, 2024

Resolved:

Jan 5, 2025

Spot Scoring Time:

Feb 1, 2024

ACX 2024 Prediction Contest

Economy & Business

Health & Pandemics

2024 Leaderboard

FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes

PBS NewsHour•Sep 17, 2025

New Alzheimer’s trial explores if weight-loss ingredient could help fight disease

Independent•Sep 17, 2025

Daily weight loss pill can help cut body weight by a fifth, trial shows

Guardian•Sep 17, 2025

Learn more about Metaculus NewsMatch